CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Sanofi-Aventis v. Cobalt Pharmaceuticals, Inc.

1:05-cv-08055

Overview

Case Number 1:05-cv-08055
Filing Date 2005-09-16
Status Terminated
Termination Date 2007-07-16
Court District Court, S.D. New York (nysd)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement

Parties

Defendant

Cobalt Pharmaceuticals, Inc. Operating Company

Represented By

1 Attorneys Listed

Brian Roy Socolow

Loeb & Loeb LLP

Tel: +1 (212) 407-4872
Fax: +1 (212) 407-4990

345 Park Avenue, New York, NY 10154

Plaintiff

Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership Operating Company

Represented By

6 Attorneys Listed

William Ericson Solander

Fitzpatrick, Cella, Harper & Scinto(NYC)

Tel: +1 (212) 218-2100
Fax: +1 (212) 218-2200

Fitzpatrick, Cella, Harper & Scinto(NYC), 1290 Avenue of the Americas

Robert Louis Baechtold

Fitzpatrick, Cella, Harper & Scinto(NYC)

Tel: +1 (212) 218-2213
Fax: +1 (212) 218-2200

Fitzpatrick, Cella, Harper & Scinto(NYC), 1290 Avenue of the Americas

Richard J Stark

Cravath, Swaine & Moore LLP

Tel: +1 (212) 474-1000
Fax: +1 (212) 474-3700

825 Eighth Avenue, New York, NY 10019

John D. Murnane

Venable LLP

Tel: +1 (212) 218-2527

1290 Avenue of the Americas, New York, NY 10104

Evan R Chesler

Cravath, Swaine & Moore LLP

Tel: +1 (212) 474-1000
Fax: +1 (212) 474-3700

825 Eighth Avenue, New York, NY 10019

David Noah Greenwald

Cravath, Swaine & Moore LLP

Tel: +1 (212) 474-1000
Fax: +1 (212) 474-3700

825 Eighth Avenue, New York, NY 10019

Sanofi-Synthelabo, Inc. Operating Company

Represented By

6 Attorneys Listed

William Ericson Solander

Fitzpatrick, Cella, Harper & Scinto(NYC)

Tel: +1 (212) 218-2100
Fax: +1 (212) 218-2200

Fitzpatrick, Cella, Harper & Scinto(NYC), 1290 Avenue of the Americas

Robert Louis Baechtold

Fitzpatrick, Cella, Harper & Scinto(NYC)

Tel: +1 (212) 218-2213
Fax: +1 (212) 218-2200

Fitzpatrick, Cella, Harper & Scinto(NYC), 1290 Avenue of the Americas

Richard J Stark

Cravath, Swaine & Moore LLP

Tel: +1 (212) 474-1000
Fax: +1 (212) 474-3700

825 Eighth Avenue, New York, NY 10019

John D. Murnane

Venable LLP

Tel: +1 (212) 218-2527

1290 Avenue of the Americas, New York, NY 10104

Evan R Chesler

Cravath, Swaine & Moore LLP

Tel: +1 (212) 474-1000
Fax: +1 (212) 474-3700

825 Eighth Avenue, New York, NY 10019

David Noah Greenwald

Cravath, Swaine & Moore LLP

Tel: +1 (212) 474-1000
Fax: +1 (212) 474-3700

825 Eighth Avenue, New York, NY 10019

Sanofi-Aventis Operating Company

Represented By

6 Attorneys Listed

William Ericson Solander

Fitzpatrick, Cella, Harper & Scinto(NYC)

Tel: +1 (212) 218-2100
Fax: +1 (212) 218-2200

Fitzpatrick, Cella, Harper & Scinto(NYC), 1290 Avenue of the Americas

Robert Louis Baechtold

Fitzpatrick, Cella, Harper & Scinto(NYC)

Tel: +1 (212) 218-2213
Fax: +1 (212) 218-2200

Fitzpatrick, Cella, Harper & Scinto(NYC), 1290 Avenue of the Americas

Richard J Stark

Cravath, Swaine & Moore LLP

Tel: +1 (212) 474-1000
Fax: +1 (212) 474-3700

825 Eighth Avenue, New York, NY 10019

John D. Murnane

Venable LLP

Tel: +1 (212) 218-2527

1290 Avenue of the Americas, New York, NY 10104

Evan R Chesler

Cravath, Swaine & Moore LLP

Tel: +1 (212) 474-1000
Fax: +1 (212) 474-3700

825 Eighth Avenue, New York, NY 10019

David Noah Greenwald

Cravath, Swaine & Moore LLP

Tel: +1 (212) 474-1000
Fax: +1 (212) 474-3700

825 Eighth Avenue, New York, NY 10019

Court & Judges

Court

District Court, S.D. New York (nysd)

Global Patent Family Cross-Litigation Radar

CasLoc 360ยฐ Radar 6 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

๐Ÿ‡บ๐Ÿ‡ธ
U.S. District Courts 1 proceeding
๐Ÿ›๏ธ
USPTO PTAB Trials Counterparts in force
๐Ÿ‡ช๐Ÿ‡บ
Unified Patent Court (UPC) Counterparts in force
๐Ÿ‡ฉ๐Ÿ‡ช
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (6): FR ๐Ÿ‡บ๐Ÿ‡ธ US
Parallel Proceedings Across Jurisdictions (1 found):
U.S. Courts: 1
U.S. District Court 2002-05-14
1:02-cv-03672

Sanofi-Synthelabo v. Dr. Reddy's Labs

Asserted Patent
Status: NYSD
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US4847265
Dextro-rotatory enantiomer of methyl alpha-5 (4,5,6,7-tetrahydro (3,2-c) thieno pyridyl) (2-chlorophenyl)-acetate and the pharmaceutical compositions containing it
Filed: 1988-02-12
Issued: 1989-07-11
Expired (Term Ended)
Expires: 2001-11-17

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. ยง 283) Statutorily Barred

Statutorily Barred โ€” Patent expired. Under 35 U.S.C. ยง 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term โ€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. ยง 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Docket Entries

(3 total)
Pleading / Complaint

COMPLAINT against Cobalt Pharmaceuticals, Inc.. (Filing Fee $ 250.00, Receipt Number 555579)Document filed by Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership, Sanofi-Aventis, Sanofi-Synthelabo, Inc.(jeh, ) Additional attachment(s) added on 9/26/2005 (lb, ). (Entered: 09/19/2005)

Entry #1 • 2005-09-16
PACER Document

STATEMENT OF RELATEDNESS re: that this action be filed as related to 02cv2255 (SHS). Document filed by Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership, Sanofi-Aventis, Sanofi-Synthelabo, Inc.(jeh, ) (Entered: 09/19/2005)

Entry #5 • 2005-09-16
PACER Document

JUDGMENT in favor of Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership, Sanofi-Aventis, Sanofi-Synthelabo, Inc. against Cobalt Pharmaceuticals, Inc. and enjoining Colbalt Pharmaceuticals, Inc. from engaging in the commercial manufacture, use, offer to sell or sale within the United states, or importation into the United states of drug products as claimed in U.S. Patent No. 4,847,265, until the expiration. (Signed by Judge Sidney H. Stein on 7/12/07) (ml) (Entered: 07/16/2007)

Entry #14 • 2007-07-16
PACER Document

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc